Literature DB >> 177371

Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.

Y H Thong, S A Hensen, M M Vincent, D A Fuccillo, W A Stiles, J A Bellanti.   

Abstract

A new 51Cr-release microassay is described for the measurement of cell-mediated immunity to cytomegalovirus, using cryopreserved target cells acutely infected with cytomegalovirus.

Mesh:

Substances:

Year:  1976        PMID: 177371      PMCID: PMC420656          DOI: 10.1128/iai.13.2.643-645.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids.

Authors:  W P ROWE; J W HARTLEY; S WATERMAN; H C TURNER; R J HUEBNER
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

2.  Herpesvirus hominis types I and II: a specific microindirect hemagglutination test.

Authors:  D A Fuccillo; F L Moder; L W Catalano; M M Vincent; J L Sever
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

3.  Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

4.  A 51 Cr microassay technique for cell-mediated immunity to viruses.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

5.  Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity.

Authors:  R Labowskie; R Edelman; R Rustigian; J A Bellanti
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

  5 in total
  12 in total

1.  Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.

Authors:  R C Gehrz; S R Rutzick
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

2.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

3.  Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test.

Authors:  C H Ten Napel; T H The; J Bijker; G C De Gast; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  Rickettsial perimyocarditis--a follow-up study.

Authors:  B Maisch
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

5.  Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.

Authors:  A Moller-Larsen; I Heron; S Haahr
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  Delayed hypersensitivity to murine cytomegalovirus and its depression during pregnancy.

Authors:  K T Chong; C A Mims
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.

Authors:  B Maisch; R Trostel-Soeder; E Stechemesser; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

8.  Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leucocytes.

Authors:  S E Starr; T Garrabrant
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

9.  Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency.

Authors:  T Tamura; S Chiba; W Abo; Y Chiba; T Nakao
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.

Authors:  L Kutinová; V Vonka
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.